Hitting HIT: Heparin therapy

(Ludwig-Maximilians-Universität München) Heparin is widely used as an anticoagulant, but evokes in some patients a potentially life-threatening condition called HIT. Clinical scientists at Ludwig-Maximilians-Universitaet (LMU) in Munich have now shown that inhibition of a single enzyme may markedly reduce this risk.